Loading…
Lobbying Income
$13.6M
Filings
564
Unique Clients
18
Active Period
2010–2026
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Air Carrier Access Amendments Act of 2021
2021 · third_quarter · Client: LIFEVAC LLC
Raised awareness regarding FDA Class II airway clearance devices. Discussed S.642 - Air Carrier Access Amendments Act of 2021 and H.R.1696 - Air Carrier Access Amendments Act of 2021.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1696
Air Carrier Access Amendments Act of 2021
2021 · third_quarter · Client: LIFEVAC LLC
Raised awareness regarding FDA Class II airway clearance devices. Discussed S.642 - Air Carrier Access Amendments Act of 2021 and H.R.1696 - Air Carrier Access Amendments Act of 2021.
Client expense: — · Firm income: $30,000
Matched citations: S.642
Air Carrier Access Amendments Act of 2021
2021 · third_quarter · Client: LIFEVAC LLC
Raised awareness regarding FDA Class II airway clearance devices. Discussed S.642 - Air Carrier Access Amendments Act of 2021 and H.R.1696 - Air Carrier Access Amendments Act of 2021.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1696
Air Carrier Access Amendments Act of 2021
2021 · third_quarter · Client: LIFEVAC LLC
Raised awareness regarding FDA Class II airway clearance devices. Discussed S.642 - Air Carrier Access Amendments Act of 2021 and H.R.1696 - Air Carrier Access Amendments Act of 2021.
Client expense: — · Firm income: $30,000
Matched citations: S.642
Lower Health Care Costs Act
2019 · second_quarter · Client: SCILEX HOLDING COMPANY
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $20,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · second_quarter · Client: SCILEX HOLDING COMPANY
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $20,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · third_quarter · Client: SCILEX HOLDING COMPANY
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD); and non-opioid alternatives.
Client expense: — · Firm income: $30,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · third_quarter · Client: SCILEX HOLDING COMPANY
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD); and non-opioid alternatives.
Client expense: — · Firm income: $30,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · third_quarter · Client: Sorrento Therapeutics, Inc.
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $20,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · third_quarter · Client: Sorrento Therapeutics, Inc.
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $20,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · second_quarter · Client: Sorrento Therapeutics, Inc.
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $20,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · second_quarter · Client: Sorrento Therapeutics, Inc.
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $20,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · second_quarter · Client: SCILEX HOLDING COMPANY
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $20,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · second_quarter · Client: SCILEX HOLDING COMPANY
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $20,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · second_quarter · Client: Sorrento Therapeutics, Inc.
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $15,000
Matched citations: S.1895
Lower Health Care Costs Act
2019 · second_quarter · Client: Sorrento Therapeutics, Inc.
Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).
Client expense: — · Firm income: $15,000
Matched citations: S.1895
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019
2018 · fourth_quarter · Client: TAUZIN STRATEGIC NETWORKS (ON BEHALF OF CORNING INC )
Work related to H.R.5961 and S.2976, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5961
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · fourth_quarter · Client: TAUZIN STRATEGIC NETWORKS (ON BEHALF OF CORNING INC )
Issues related to pharmaceutical supply chain and S.2852 and HR 6378 (both entitled the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018).
Client expense: — · Firm income: $30,000
Matched citations: HR 6378
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · fourth_quarter · Client: TAUZIN STRATEGIC NETWORKS (ON BEHALF OF CORNING INC )
Issues related to pharmaceutical supply chain and S.2852 and HR 6378 (both entitled the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018).
Client expense: — · Firm income: $30,000
Matched citations: S.2852
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019
2018 · fourth_quarter · Client: TAUZIN STRATEGIC NETWORKS (ON BEHALF OF CORNING INC )
Work related to H.R.5961 and S.2976, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill.
Client expense: — · Firm income: $30,000
Matched citations: S.2976
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019
2018 · second_quarter · Client: TAUZIN STRATEGIC NETWORKS (ON BEHALF OF CORNING INC )
Work related to H.R.5961 and S.2976, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5961
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · second_quarter · Client: TAUZIN STRATEGIC NETWORKS (ON BEHALF OF CORNING INC )
Issues related to pharmaceutical supply chain and S.2852 and HR 6378 (both entitled the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018).
Client expense: — · Firm income: $30,000
Matched citations: HR 6378
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · second_quarter · Client: TAUZIN STRATEGIC NETWORKS (ON BEHALF OF CORNING INC )
Issues related to pharmaceutical supply chain and S.2852 and HR 6378 (both entitled the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018).
Client expense: — · Firm income: $30,000
Matched citations: S.2852
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019
2018 · second_quarter · Client: TAUZIN STRATEGIC NETWORKS (ON BEHALF OF CORNING INC )
Work related to H.R.5961 and S.2976, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill.
Client expense: — · Firm income: $30,000
Matched citations: S.2976
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019
2018 · third_quarter · Client: TAUZIN STRATEGIC NETWORKS (ON BEHALF OF CORNING INC )
Work related to H.R.5961 and S.2976, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5961
Source: Senate LDA